hemangiol
pierre fabre medicament - propranolola hidrohlorīds - hemangioma - beta blocking agents - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
anaprilīns 10 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 10 mg
anaprilīns 40 mg tabletes
olainfarm, as, latvia - propranolola hidrohlorīds - tablete - 40 mg
calvinia 10 mg mutē disperģējamās tabletes
gedeon richter plc., hungary - rizatriptāns - mutē disperģējamā tablete - 10 mg
ranigast 75 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - ranitidīns - apvalkotā tablete - 75 mg
ranigast 150 mg apvalkotās tabletes
pharmaceutical works polpharma sa, poland - ranitidīns - apvalkotā tablete - 150 mg
adrenaline sopharma 1 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - epinefrīns - Šķīdums injekcijām - 1 mg/ml
biosuis m.hyo
bioveta, a.s., Čehija - mycoplasma hyopneoumoniae - emulsija injekcijām - cūkas
pimocard
eurovet animal health b.v., nīderlande - pimobendan - aromatizētas tabletes - 1.25 mg - suņi
pimocard
eurovet animal health b.v., nīderlande - pimobendan - aromatizētas tabletes - 5 mg - suņi